Glial fibrillary acidic protein in cerebrospinal fluid in humans is sensitive to various pre-analytical conditions: possible explanation and solution
Although glial fibrillary acidic protein (GFAP) has potential as a biomarker in cerebrospinal fluid, it is rarely used in clinical diagnosis due to high variability, low reliability, and poor reproducibility of results. Cerebrospinal fluid (CSF) was collected from patients (n = 167) at two sites at...
Saved in:
| Main Authors: | Björn Evertsson, Ingela Nilsson Remahl, Max Albert Hietala, Anja Finn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1627405/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
by: Mehri Salari, et al.
Published: (2023-03-01) -
Bacteriological study of the cerebrospinal fluid(CSF) of children with meningitis in Baghdad
by: Ahmed .K.H.Al Hassan, et al.
Published: (2023-01-01) -
The Cerebrospinal Fluid Secretion Rate Increases in Awake and Freely Moving Rats but Differs With Experimental Methodology
by: Trine L. Toft‐Bertelsen, et al.
Published: (2025-05-01) -
The influence of the choroid plexus on brain function: beyond its role in cerebrospinal fluid production
by: Sayako Katada, et al.
Published: (2025-07-01) -
Analysis of cerebrospinal fluid tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adult
by: Michael Youssef, et al.
Published: (2025-09-01)